Otolaryngology Online Journal

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +44 151 808 1136

Short Communication - Otolaryngology Online Journal (2024) Volume 14, Issue 1

Oropharyngeal Cancer: Early Detection and Screening Guidelines

Katrina Jenkins *

Department of Oral Radiology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania

*Corresponding Author:
Katrina Jenkins
Department of Oral Radiology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
E-mail: jenkinskatrina@yahoo.com

Received: 29-Dec-2023, Manuscript No. JORL-23- 123749; Editor assigned: 01-Jan-2024, PreQC No. JORL-23- 123749; Reviewed:15-Jan-2024, QC No. JORL-23- 123749; Revised:20-Jan-2024, Manuscript No. JORL-23- 123749 (R); Published:27-Jan-2024, DOI:10.35841/ jorl-14.1.368

Visit for more related articles at Otolaryngology Online Journal

Introduction

Early detection and screening guidelines play a pivotal role in managing oropharyngeal cancer, allowing for timely intervention and improved treatment outcomes. However, unlike some other cancers, there isn't a widely adopted routine screening test for oropharyngeal cancer. Instead, awareness of risk factors and symptoms remains crucial for early detection [1].

Risk Factors: Understanding the risk factors associated with oropharyngeal cancer is key. Tobacco and alcohol use, human papillomavirus (HPV) infection, and a history of oral lesions or prior head and neck cancer are among the primary risk factors [2].

Signs and Symptoms: Early signs such as persistent sore throat, hoarseness, difficulty swallowing, or a lump in the neck should prompt individuals to seek medical evaluation. Increased awareness of these symptoms can lead to early detection and subsequent treatment [3].

Physical Exams: Regular visits to healthcare professionals for oral and neck examinations are valuable in detecting suspicious lesions or abnormalities at an early stage.HPV Vaccination: Given the strong association between HPV infection and oropharyngeal cancer, HPV vaccination, ideally before sexual debut, can significantly reduce the risk of developing this type of cancer [4].

Educational Campaigns: Public health campaigns aimed at raising awareness about risk factors, symptoms, and the importance of seeking timely medical attention can contribute to early detection [5].

High-risk Populations: Individuals with known risk factors, such as heavy smokers or those with a history of HPV infection, should be particularly vigilant about symptoms and consider more frequent screenings [6].

Diagnostic Procedures: Biopsies, imaging tests like CT scans and MRIs, and endoscopic examinations are among the diagnostic tools used when symptoms or physical exams suggest the presence of oropharyngeal cancer [7].

Role of Healthcare Providers: Encouraging patients to report concerning symptoms, conducting thorough examinations during routine visits, and discussing risk factors and preventive measures are crucial roles of healthcare providers in early detection [8].

Challenges in Early Detection: Oropharyngeal cancer symptoms can mimic other conditions, leading to delayed diagnosis. Lack of routine screening tests also poses challenges in detecting the cancer at an early, more treatable stage [9].

Global Guidelines: Various medical organizations worldwide provide guidelines for healthcare providers regarding risk assessment, screening, and early detection strategies for oropharyngeal cancer [10].

conclusion

While routine screening tests for oropharyngeal cancer are not widely established, awareness of risk factors, symptoms, regular physical exams, and patient education remain critical. Early detection greatly influences treatment success and patient outcomes. Public health initiatives, enhanced healthcare provider awareness, and advancements in screening technologies hold the potential to improve early detection rates, ultimately reducing the burden of oropharyngeal cancer

References

  1. Mesia R, Iglesias L, Lambea J, et al. SEOM clinical guidelines for the treatment of head and neck cancer (2020). Clinical and Translational Oncology. 2021 May;23:913-21.

    2. Indexed at, Google Scholar, Cross Ref

  2. Faur CI, Falamas A, Chirila M, et al. Raman spectroscopy in oral cavity and oropharyngeal cancer: a systematic review. International Journal of Oral and Maxillofacial Surgery. 2022 Nov 1;51(11):1373-81.

    3. Indexed at, Google Scholar, Cross Ref

  3. Paleri V, Wight RG, Silver CE, et al. Comorbidity in head and neck cancer: a critical appraisal and recommendations for practice. Oral oncology. 2010 Oct 1;46(10):712-9.

    4. Indexed at, Google Scholar, Cross Ref

  4. Yang S, Park JW, Min K, et al. Clinical Practice Guidelines for Oropharyngeal Dysphagia. Annals of Rehabilitation Medicine. 2023 Jul 30;47(Suppl 1):S1-26.

    5. Indexed at, Google Scholar, Cross Ref

  5. Fauzi FH, Hamzan NI, Ab Rahman N, et al. Detection of human papillomavirus in oropharyngeal squamous cell carcinoma. Journal of Zhejiang University. Science. B. 2020 Dec;21(12):961.

    6. Indexed at, Google Scholar, Cross Ref

  6. Burd EM. Human papillomavirus laboratory testing: the changing paradigm. Clinical microbiology reviews. 2016 Apr;29(2):291-319.

    7. Indexed at, Google Scholar, Cross Ref

  7. Smirani R, Poursac N, Naveau A, et al. Orofacial consequences of systemic sclerosis: A systematic review. Journal of Scleroderma and Related Disorders. 2018 Feb;3(1):81-90.

    8. Indexed at, Google Scholar, Cross Ref

  8. Reich M, Licitra L, Vermorken JB, et al. Best practice guidelines in the psychosocial management of HPV-related head and neck cancer: recommendations from the European Head and Neck Cancer Society's Make Sense Campaign. Annals of Oncology. 2016 Oct 1;27(10):1848-54.

    9. Indexed at, Google Scholar, Cross Ref

  9. Levy AD, Carucci LR, Bartel TB, et al. ACR Appropriateness Criteria® Dysphagia. Journal of the American College of Radiology. 2019 May 1;16(5):S104-15.

    10. Indexed at, Google Scholar, Cross Ref

  10. Whang SN, Filippova M, Duerksen-Hughes P. Recent progress in therapeutic treatments and screening strategies for the prevention and treatment of HPV-associated head and neck cancer. Viruses. 2015 Sep 17;7(9):5040-65.

    11. Indexed at, Google Scholar, Cross Ref

Get the App